110 related articles for article (PubMed ID: 15452129)
1. Identification of the MMRN1 binding region within the C2 domain of human factor V.
Jeimy SB; Woram RA; Fuller N; Quinn-Allen MA; Nicolaes GA; Dahlbäck B; Kane WH; Hayward CP
J Biol Chem; 2004 Dec; 279(49):51466-71. PubMed ID: 15452129
[TBL] [Abstract][Full Text] [Related]
2. Location of the multimerin 1 binding site in coagulation factor V: an update.
Jeimy SB; Quinn-Allen MA; Fuller N; Kane WH; Hayward CP
Thromb Res; 2008; 123(2):352-4. PubMed ID: 18452976
[TBL] [Abstract][Full Text] [Related]
3. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
[TBL] [Abstract][Full Text] [Related]
4. Human platelets contain forms of factor V in disulfide-linkage with multimerin.
Hayward CP; Fuller N; Zheng S; Adam F; Jeimy SB; Horsewood I; Quinn-Allen MA; Kane WH
Thromb Haemost; 2004 Dec; 92(6):1349-57. PubMed ID: 15583744
[TBL] [Abstract][Full Text] [Related]
5. Factor V is complexed with multimerin in resting platelet lysates and colocalizes with multimerin in platelet alpha-granules.
Hayward CP; Furmaniak-Kazmierczak E; Cieutat AM; Moore JC; Bainton DF; Nesheim ME; Kelton JG; Côté G
J Biol Chem; 1995 Aug; 270(33):19217-24. PubMed ID: 7642592
[TBL] [Abstract][Full Text] [Related]
6. The factor V C1 domain is involved in membrane binding: identification of functionally important amino acid residues within the C1 domain of factor V using alanine scanning mutagenesis.
Saleh M; Peng W; Quinn-Allen MA; Macedo-Ribeiro S; Fuentes-Prior P; Bode W; Kane WH
Thromb Haemost; 2004 Jan; 91(1):16-27. PubMed ID: 14691564
[TBL] [Abstract][Full Text] [Related]
7. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.
Ortel TL; Devore-Carter D; Quinn-Allen M; Kane WH
J Biol Chem; 1992 Feb; 267(6):4189-98. PubMed ID: 1740460
[TBL] [Abstract][Full Text] [Related]
8. The factor V activation paradox.
Orfeo T; Brufatto N; Nesheim ME; Xu H; Butenas S; Mann KG
J Biol Chem; 2004 May; 279(19):19580-91. PubMed ID: 14982929
[TBL] [Abstract][Full Text] [Related]
9. Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis.
Kim SW; Quinn-Allen MA; Camp JT; Macedo-Ribeiro S; Fuentes-Prior P; Bode W; Kane WH
Biochemistry; 2000 Feb; 39(8):1951-8. PubMed ID: 10684644
[TBL] [Abstract][Full Text] [Related]
10. The phosphatidylserine binding site of the factor Va C2 domain accounts for membrane binding but does not contribute to the assembly or activity of a human factor Xa-factor Va complex.
Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
Biochemistry; 2005 Jan; 44(2):711-8. PubMed ID: 15641797
[TBL] [Abstract][Full Text] [Related]
11. A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.
Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
Blood; 2008 Oct; 112(7):2795-802. PubMed ID: 18587009
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.
Ortel TL; Quinn-Allen MA; Charles LA; Devore-Carter D; Kane WH
J Clin Invest; 1992 Dec; 90(6):2340-7. PubMed ID: 1281831
[TBL] [Abstract][Full Text] [Related]
13. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
Marquette KA; Pittman DD; Kaufman RJ
Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
[TBL] [Abstract][Full Text] [Related]
14. Trp2063 and Trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.
Peng W; Quinn-Allen MA; Kim SW; Alexander KA; Kane WH
Biochemistry; 2004 Apr; 43(14):4385-93. PubMed ID: 15065883
[TBL] [Abstract][Full Text] [Related]
15. Structural requirements for expression of factor Va activity.
Kalafatis M; Beck DO; Mann KG
J Biol Chem; 2003 Aug; 278(35):33550-61. PubMed ID: 12788947
[TBL] [Abstract][Full Text] [Related]
16. Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex.
Kim SW; Ortel TL; Quinn-Allen MA; Yoo L; Worfolk L; Zhai X; Lentz BR; Kane WH
Biochemistry; 1999 Aug; 38(35):11448-54. PubMed ID: 10471296
[TBL] [Abstract][Full Text] [Related]
17. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
18. The cDNA sequence of human endothelial cell multimerin. A unique protein with RGDS, coiled-coil, and epidermal growth factor-like domains and a carboxyl terminus similar to the globular domain of complement C1q and collagens type VIII and X.
Hayward CP; Hassell JA; Denomme GA; Rachubinski RA; Brown C; Kelton JG
J Biol Chem; 1995 Aug; 270(31):18246-51. PubMed ID: 7629143
[TBL] [Abstract][Full Text] [Related]
19. Completed three-dimensional model of human coagulation factor va. Molecular dynamics simulations and structural analyses.
Orban T; Kalafatis M; Gogonea V
Biochemistry; 2005 Oct; 44(39):13082-90. PubMed ID: 16185076
[TBL] [Abstract][Full Text] [Related]
20. Amino acids Glu323, Tyr324, Glu330, and Val331 of factor Va heavy chain are essential for expression of cofactor activity.
Singh LS; Bukys MA; Beck DO; Kalafatis M
J Biol Chem; 2003 Jul; 278(30):28335-45. PubMed ID: 12738785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]